BlackRock’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,542
Closed -$775 5485
2023
Q4
$775 Hold
3,542
﹤0.01% 5278
2023
Q3
$1.12K Sell
3,542
-1,101
-24% -$763 ﹤0.01% 5322
2023
Q2
$4.3K Sell
4,643
-28,131
-86% -$20.3K ﹤0.01% 5324
2023
Q1
$29.3K Buy
32,774
+900
+3% +$1.16K ﹤0.01% 5203
2022
Q4
$54.7K Buy
31,874
+600
+2% +$1.32K ﹤0.01% 5204
2022
Q3
$65K Sell
31,274
-750
-2% -$1.5K ﹤0.01% 5302
2022
Q2
$83K Sell
32,024
-450
-1% -$1.44K ﹤0.01% 5287
2022
Q1
$142K Sell
32,474
-1,350
-4% -$5.64K ﹤0.01% 5198
2021
Q4
$155K Sell
33,824
-973
-3% -$5.24K ﹤0.01% 5159
2021
Q3
$210K Sell
34,797
-652
-2% -$4.7K ﹤0.01% 4975
2021
Q2
$366K Sell
35,449
-343,118
-91% -$3.28M ﹤0.01% 4770
2021
Q1
$2.89M Buy
378,567
+12,372
+3% +$81.9K ﹤0.01% 4171
2020
Q4
$1.38M Buy
366,195
+22,271
+6% +$85.9K ﹤0.01% 4138
2020
Q3
$1.22M Buy
343,924
+853
+0.2% +$4.98K ﹤0.01% 4057
2020
Q2
$3.17M Buy
+343,071
New +$2.45M ﹤0.01% 3690

Other funds holding NMRD

BlackRock's NMRD Position: Q1 2024 in Review

BlackRock sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2024, closing a stake of 3,542 shares — an estimated $775 sold.

BlackRock first reported a position in NMRD in Q2 2020 and held it in 15 quarters. The position peaked at $3.17M in Q2 2020. 2 funds tracked by Wall St. Rank hold NMRD as of Q1 2024.

  • BlackRock reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • BlackRock sold 3,542 Nemaura Medical, Inc. Common Stock shares in Q1 2024, an estimated $775.
  • BlackRock first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
  • BlackRock's Nemaura Medical, Inc. Common Stock position peaked at $3.17M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2024.

Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.